Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Helga Preiss"'
Autor:
Giulia Montrasio, Martin F. Reiner, Andrea Wiencierz, Stefanie Aeschbacher, Christine Baumgartner, Nicolas Rodondi, Michael Kühne, Giorgio Moschovitis, Helga Preiss, Michael Coslovsky, Maria L. De Perna, Leo H. Bonati, David Conen, Stefan Osswald, Juerg H. Beer, Pascal Koepfli
BACKGROUND Direct oral anticoagulants (DOACs) have a favourable risk-benefit profile compared to vitamin K-antagonists (VKAs) in atrial fibrillation (AF). Dosing is based on age, weight and renal function, without need of routine monitoring. METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d03dedc4fb3b9554042e23af7fbb45f
https://doi.org/10.5167/uzh-229301
https://doi.org/10.5167/uzh-229301
Autor:
Andréea Anamaria Moldovan, Ilker Uçkay, Giulia Montrasio, Benjamin A. Lipsky, Philipp Kriechling, İmke Janssen, Helga Preiss, Tanja Huber
Publikováno v:
Journal of Bone and Joint Infection, Vol 5, Pp 16-24 (2020)
Journal of Bone and Joint Infection
Journal of Bone and Joint Infection
Flucloxacillin (FLU) administered by the oral route is widely used for treating various infections, but there are no published retrospective or prospective trials of its efficacy, or its advantages or disadvantages compared to parenteral treatment or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93564316a7da4000868f64ca484f17af
https://jbji.copernicus.org/articles/5/16/2020/jbji-5-16-2020.pdf
https://jbji.copernicus.org/articles/5/16/2020/jbji-5-16-2020.pdf
